Bruker Corporation (BRKR)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 183,400 | 488,300 | 645,500 | 1,068,200 | 681,800 |
| Short-term investments | US$ in thousands | — | 12,000 | 0 | 100,000 | 50,000 |
| Total current liabilities | US$ in thousands | 1,281,300 | 1,202,100 | 914,300 | 938,500 | 791,900 |
| Cash ratio | 0.14 | 0.42 | 0.71 | 1.24 | 0.92 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($183,400K
+ $—K)
÷ $1,281,300K
= 0.14
The cash ratio for Bruker Corporation has shown fluctuations over the past five years. As of December 31, 2020, the cash ratio stood at 0.92, indicating that the company had sufficient cash to cover 92% of its current liabilities.
By December 31, 2021, the cash ratio improved to 1.24, suggesting an increase in the company's liquidity position with the ability to cover 124% of its current liabilities with cash on hand.
However, by the end of 2022, the cash ratio decreased to 0.71, which may indicate a potential strain on the company's liquidity, as it could only cover 71% of its current liabilities with available cash.
The trend continued to worsen in 2023, with the cash ratio dropping to 0.42, signaling further liquidity challenges. The company's ability to meet its short-term obligations solely with cash diminished to covering only 42% of its current liabilities.
As of December 31, 2024, the cash ratio reached its lowest point at 0.14, underscoring significant liquidity constraints for Bruker Corporation, with cash on hand enough to cover just 14% of its current liabilities. This downward trend may raise concerns about the company's ability to handle its short-term financial obligations using its existing cash reserves.
Peer comparison
Dec 31, 2024